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Background: NK produce IFN- and GM-CSF in response to CpG-ODN in the presence of accessory cytokines.
Results: This production involves NF-B, STAT3, UNC93b1 and IL-12. IFN- is MyD88- and TLR9-dependent, whereas
GM-CSF depends on the adaptor STING.
Conclusion: NK present an alternative mechanism of sensing of CpG-ODN.
Significance: These results open new horizons in the understanding of NK cells activation by microbial DNA.
Natural killer (NK) cells are important for innate immunity in
particular through the production of IFN- and GM-CSF. Both
cytokines are important in restoration of immune function of
tolerized leukocytes under inflammatory events. The expres-
sionofTLRs inNKcells has beenwidely studiedby analyzing the
mRNA of these receptors, rarely seeking their protein expres-
sion.Wepreviously showed thatmurine spleenNK cells express
TLR9 intracellularly and respond to CpG oligodeoxynucleotide
(CpG-ODN) by producing IFN- and GM-CSF. However, to get
such production the presence of accessory cytokines (such as
IL-15 and IL-18) was required, whereas CpG-ODN or accessory
cytokines alonedidnot induce IFN-orGM-CSF.We showhere
that TLR9 overlaps with the Golgi apparatus in NK cells. Fur-
thermore, CpG-ODN stimulation in the presence of accessory
cytokines induces the phosphorylation of c-Jun, STAT3, and
IB. IFN- and GM-CSF production requires NF-B and
STAT3 activation as well as Erk-dependent mechanisms for
IFN- and p38 signaling for GM-CSF. Using knock-out-mice,
we show that UNC93b1 and IL-12 (produced by NK cells them-
selves) are also necessary for IFN- and GM-CSF production.
IFN- production was found to be MyD88- and TLR9-depen-
dent, whereas GM-CSF was TLR9-independent but dependent
on STING (stimulator of interferon genes), a cytosolic adaptor
recently described forDNAsensing.Our study thereby allowsus
to gain insight into the mechanisms of synergy between acces-
sory cytokines andCpG-ODN inNKcells. It also identifies a new
and alternative signaling pathway for CpG-ODN in murine NK
cells.
Natural killer (NK)3 cells are important actors of innate
immunity with a predominant role during viral infections. It
has now been clearly established that NK cells also play a key
role during bacterial infection (for review see, Ref. 1). NK cells
contribute to the inflammatory reaction by the production of
many cytokines, particularly two potent immune-stimulatory
cytokines IFN- and GM-CSF, with each playing a key role in
innate immunity (2, 3). IFN- is a well known proinflammatory
cytokine and has been recognized as a factor involved in endo-
toxin-induced lethality (4, 5). GM-CSF has similarly been
shown to contribute to many inflammatory disorders (6).
NK cells have been shown to express Toll-like receptors
(TLRs), primarily determined by PCR measurement of TLR
transcript, whereas few have demonstrated expression at the
protein level. Various detection methods have yielded conflict-
ing results (mRNA or surface expression) (7–10). We recently
showed that murine NK cells do indeed express TLR2, TLR4,
and TLR9 at the protein level. In contrast to other leukocytes
such as macrophages in which TLR2 and TLR4 are present on
the surface, NK cells express these receptors intracellularly,
similarly to TLR9 (11). Additionally, we found that purified
splenic naive NK cells were highly responsive to CpG-ODN, a
synthetic oligodeoxynucleotide mimicking bacterial DNA rec-
ognized as an agonist of TLR9. CpG-ODN is a potent inducer of
IFN- andGM-CSF, but only in the presence of accessory cyto-
kines such as IL-2, IL-15, and/or IL-18 (11), which alone are
unable to induce cytokine production. Thus, NK cells require
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two signals for IFN- andGM-CSF production: from accessory
cytokines and from the receptors sensing CpG-ODN.
The aim of the present study was to decipher the mecha-
nisms involved in IFN- andGM-CSF induction and to identify
the intracellular actors during production. We are first to
report that TLR9 expression overlaps with the Golgi apparatus
in NK cells. We found that CpG-ODN stimulation in the pres-
ence of accessory cytokines induces the phosphorylation of
c-Jun, STAT3, and IB. IFN- and GM-CSF production
requiresNF-B and STAT3 activation aswell as Erk-dependent
mechanisms for IFN- and p38 signaling for GM-CSF. Using
knock-out mice GM-CSF production was surprisinglyMyD88-
and TLR9-independent in contrast to IFN-, which used the
classical CpG-ODN sensing via TLR9. Therefore, we investi-
gated the possible role of the STING (stimulator of interferon
genes), a cytosolic adaptor recently described and associated
with TLR-independent sensing of bacterial DNA (12, 13). Our
results indicate that NK cell cytokine production may occur
independently of TLR9, yet require STING and UNC93b1 as
well as NK-produced IL-12.
EXPERIMENTAL PROCEDURES
Reagents—Antibodies against the following antigens were
used: anti-IL-12p40/p70-PE, anti-NKp46-V450, and anti-
NKp46-A647 were from BD Biosciences, and anti-TLR9/
CD289-A488 was from Imgenex (San Diego, CA). The corre-
sponding isotype and fluorophore controls were obtained from
the same companies. For immunofluorescence, the antibodies
against the following antigens were used: anti-TMEM173-
STING from Acris Antibodies GmbH (Herford, Germany) and
anti-p65 from Cellular Signaling Technology (Beverly, MA).
The corresponding secondary antibody, conjugated with Texas
Red and A488 respectively, were obtained from the same com-
panies. The FcReceptor-blocking reagent and the Inside stain
kit were obtained from Miltenyi Biotec (Bergisch-Gladbach,
Germany). The murine recombinant cytokines (IL-2, IL-15)
were from Peprotech, and IL-18 was fromMedical and Biolog-
ical Laboratories. ELISA kits to detect GM-CSF, IFN-, IL-1,
IL-6, and TNF- were obtained from R&D Systems and used
according to the recommendations of the manufacturer. The
multiplex combination used to detect phosphorylated AKT,
ERK1–2, I, c-Jun, JNK, p38, STAT2, and STAT3 was pro-
vided by Bio-Rad Laboratories. The murine CpG-ODN
sequence was as follows: 5-TCCATGACGTTCCTGAT-
GCT-3 and was synthesized by Sigma-Genosys (The Wood-
lands, TX). The corresponding CpG-ODN sequence was cus-
tomized to be coupled to Alexa Fluor 488 (A488) by Integrated
DNA Technologies (Coralville, IA). The inhibitors were as fol-
lows: Pepinh-MYD (MyD88, 20M) was obtained from Invivo-
Gen (San Diego, CA); Stattic was used at 1 M (STAT3),
SP600125 at 10 M (c-Jun), Bay 11-7085 at 1 M (NF-B), and
SB203580 at 10 M (p38) were from TOCRIS Bioscience (Bris-
tol, UK); 10 M LY294002 (PI3K) and 20 M PD-98059
(ERK1,2) were from Calbiochem. The nucleus and Golgi appa-
ratus probes Hoechst 33342 and BODIPY-TR ceramide,
respectively, were obtained from Invitrogen. radioimmune pre-
cipitation assay buffer was obtained from Sigma Aldrich.
Mice—Studies were performed with 8- to 12-week-old male
mice. The wild-type C57BL/6(J) was obtained from Janvier (Le
Genest-St.-Isle, France). The transgenic mice in a C57BL/6
background were obtained as follows: il-12r2/ mice from
the Transgenose Institute animal breeding facility (Orléans,
France); the ifn-/R, ifn-,myd88, and tlr9/mice from the
animal facility of the Institut Pasteur (Paris, France); the trif/
mice from the animal facility of the A*STAR Singapore Immu-
nology Network (Singapore); the sting-deficient mice and
unc93b1/ from the animal facility of the University of Mas-
sachusetts Medical School (Worcester, MA). Animals were
housed in the animal facilities under specific pathogen-free
conditions. Protocols, performed in compliance with the NIH
AnimalWelfare Insurance no. A5476-01 issued on 02/07/2007,
were approved by the veterinary team of the Institut Pasteur
animal facility.
Preparation of Murine NK Cells and in Vitro Culture
Conditions—NK cells were enriched from spleen homogenates
by negative selection using the NK cell isolation kit on
untouched mouse NK cells (Miltenyi Biotec) as described pre-
viously (11). NK cell purity was assessed by flow cytometry after
CD3NKp46 staining and was95%. After purification, cells
were plated at 1 105 cells/well in 96-well plates in RPMI 1640
(LONZA, Rockland, ME) supplemented with 10% FCS (PAA
Laboratories, Pasching, Austria), streptomycin at 0.1 mg/ml,
and penicillin at 100u/ml (Sigma-Aldrich).
For GM-CSF and IFN-measurements, cells were incubated
for 48 h at 37 °C and 5%CO2 in the presence or absence of IL-15
and IL-18 (10 ng/ml) and CpG-ODN (1 M). In some experi-
ments, peritoneal cells were prepared and cultured as described
previously andwere used as controls (14). For the in vitroGolgi/
TLR9 co-localization assay, purified NK cells were first incu-
bated 30min at 4 °C in the presence of theBODIPY-TRprobe at
5M, incubated for 30min at 37 °C and 5%CO2, and then fixed
in 2% paraformaldehyde, permeabilized, and stained for intra-
cellular TLR9. The same intracellular stain protocolwas used to
stain STING in naive cells, and p65 as described by Gouin et al.
(15) (after IL-15, IL-18, and CpG-ODN stimulation). For the
STING co-localization assay, a CpG-DNAcoupled toA647was
used (1 M). The staining was analyzed using a Leica SP5 con-
focal microscope. To perform the bioplex to detect the phos-
phorylated signaling proteins, 3  106 NK cells per test were
cultured in culture tubes for 30 min or 1 h in the presence or
absence of the IL-15, IL-18, IL-15/IL-18 (10 ng/ml), and/or
CpG-ODN (1 M). Cells were then resuspended and homoge-
nized in 50 l of radioimmune precipitation assay buffer. Cell
lysates were kept at80 °C until analysis.
NK cell surface antigens were labeled in staining buffer (PBS,
2 mM EDTA, and 0.5% FCS) with antibodies at the concentra-
tion suggested by the manufacturers. Intracellular staining was
performed after fixation and permeabilization of the cells using
the Inside Stain kit (Myltenyi Biotec), according to the manu-
facturer’s instructions. All flow cytometry data were acquired
and analyzed on a MACSQuant flow cytometer (Myltenyi
Biotec).
Statistical Analysis—All experiments were performed at
least three times, using at least n 3 mice per assay. One-way
ANOVA and Fisher least significance difference test were used
Cytokine Signaling of CpG-ODN in NK Cells
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for statistical analysis. A p value  0.05 was considered to be
significant.
RESULTS
TLR9 Overlaps with the Golgi Apparatus in NK Cells and
IFN- and GM-CSF Production Requires NF-B and STAT3—
We previously showed by flow cytometry that similar to mye-
loid cells, TLR9was intracellular inmurineNK cells (11). In the
present report we confirmed this finding and in addition
showed by confocal microscopy that TLR9 overlaps with the
Golgi apparatus (Fig. 1A). A more precise localization is how-
ever difficult in primaryNK cells because of the small cytosol in
this cell type. To better understand the signaling of CpG-ODN
in NK cells, we analyzed the phosphorylation of signaling mol-
ecules described in the literature to be induced by accessory
cytokines (IL-15/IL-18) or CpG-ODN. Whole cell extracts
were prepared after 30 or 60min of stimulation and analyzed by
the Bioplex technology. Within these molecules, we observed
that IL-15 and IL-18 alone and/or together induced the phos-
phorylation of c-Jun (Fig. 1B). In the presence of CpG-ODN
and IL-15/IL-18 c-Jun phosphorylation was consistent at 30
min but appeared more sustained at 1 h as compared with
IL-15/IL-18 alone. CpG and IL-18 also induced STAT3 phos-
phorylation and the level was again higher when stimulatory
cytokines and CpG-ODN were added simultaneously. Finally,
CpG-ODN and stimulatory cytokines added alone induced
some phosphorylation on IB with higher p-IB observed
when both CpG-ODN and IL-15/IL-18 were present simulta-
neously. p38 and ERK were phosphorylated after stimulation
with CpG, IL-15/18, or their combination, but the level of acti-
vation was comparable for all conditions. No synergistic effect
was observed (data not shown). No difference in the phosphor-
ylation of the signaling molecules AKT, JNK, or STAT2 was
observed (data not shown). The contribution of various signal-
ingmolecules on IFN- and GM-CSF production was also ana-
lyzed using specific inhibitors (Fig. 1C). The optimal concen-
tration for each inhibitory drug was chosen according to the
literature (16–19) and our own experience (20). CpG-ODN or
IL-15/IL-18 alone did not induce any IFN- or GM-CSF secre-
tion. In contrast, when co-signaling they synergized inducing
thousands of pg/ml of both cytokines. This induction was com-
pletely abolished by specific inhibitors of STAT3 or NF-B and
partially diminished by the ERK1/2 inhibitor for IFN- and by
p38 inhibitor for GM-CSF.
Both Accessory Cytokines IL-15/IL-18 and CpG-ODN Are
Necessary for NF-B p65 Nuclear Translocation—Purified NK
cells were primed overnight with IL-15 and IL-18 and then
challenged with CpG-ODN. Nuclear translocation of p65 was
measured by immunofluorescence after 60-min stimulation.As
shown in Fig. 2A, no or low nuclear localization of NF-B was
present in cells stimulated with CpG-ODN or IL-15/IL-18
alone. Similarly, no nuclear localization was seen in unstimu-
latedcells (control, imagenot shown). In contrast, immunofluo-
rescence staining of the p65 subunit revealed a high nuclear
localization of this transcription factor after CpG-ODN 
IL-15/IL-18 challenge. Cells were counted in order to estimate
the percentage of nucleus positive for p65 (Fig. 2B). The per-
FIGURE 1. A, intracellular localization of TLR9 by confocal microscopy showing overlapping with the Golgi apparatus (BODIPY cytochemistry). Nucleus is
visualized with Hoechst. Scale bar, 5m. B, phosphorylated signalingmolecules profile at 30 and 60min of stimulation.DIC, differential interference contrast.
The phosphorylation is measured by bioplex technology and expressed as mean fluorescence intensity (MFI). Data are mean  S.E. of three experiments.
C, pharmacological inhibitionofp38, PI3K, c-Jun, ERK1/2, STAT3, andNF-B. Purified spleenNKcellswere cultured in thepresenceof IL-15/IL-18 (10ng/ml each)
and/or CpG-ODN (1M)with or without the inhibitors. After 48 h of in vitro stimulation, IFN- andGM-CSFweremeasured by ELISA in the supernantants. Data
are mean S.E. of five experiments. *, p 0.05; ***, p 0.001 (one-way ANOVA and Fisher least significance difference test). 30’, 30 min; 60’, 60 min.
Cytokine Signaling of CpG-ODN in NK Cells
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centage of positive cells for nuclear p65 was 	20% in cells
treated with CpG-ODN or IL-15/IL-18 alone but reached 75%
when both stimuli were present.
TLR9-independent GM-CSF Induction by CpG-ODNand the
Role of STING and UNC93b1 for Cytokine Production by NK
Cells—Using deficient mice, we evaluated whether IFN- and
GM-CSF productions were fully dependent of the TLR9 signal-
ing pathway forNK cells. In the case of IFN-, we demonstrated
an absence of production in myd88 and tlr9/ NK cells (Fig.
3A). Interestingly, IFN- production was also abolished in the
absence of UNC93b1, a molecule important for TLR9 migra-
tion from the endoplasmic reticulum to the Golgi apparatus
(21). In addition, we found a partial effect of STING, a newly
described adaptor involved in cytoplasmic sensing double-
stranded DNA (22), on IFN- production by NK cells. Indeed,
IFN- levels were significantly decreased for STING deficient
NK cells identifying a new actor involved inCpG-ODNsensing.
As shown in Fig. 3A, the absence of STING did not totally abol-
ish IFN- production, but its presence was necessary for opti-
mal production. The remaining IFN- production was com-
pletely abolished when sting/NK cells were incubated with a
MyD88 inhibitor (MyD88 peptide), suggesting the existence of
two pathways forCpG-ODNsensing: one involving STINGand
one needing the adaptor protein MyD88 for downstream sig-
naling. For GM-CSF, the results were more striking and sur-
prising, considering no significant alteration of GM-CSF pro-
duction in myd88 or tlr9/ NK cells was found. In contrast,
GM-CSF production was profoundly and significantly altered
in the absence of STING. Similar to IFN-, GM-CSF produc-
tion was totally abolished if, in addition to STING, theMyD88-
dependent pathway was blocked.
As expected, the production of both cytokines was indepen-
dent of TRIF (TIR domain-containing adaptor-inducing inter-
feron-), which was used as a negative control. We also inves-
tigated a possible role of IFN-/. Using ifn-/R/NK cells,
we showed that indeed they do not participate in the induction
mechanisms of IFN- or GM-CSF. Finally, we investigated
whether IFN- or GM-CSF may participate in one another’s
FIGURE2.A, both accessory cytokines IL-15/IL-18 andCpG-ODNarenecessary
for NF-B p65 nuclear translocation. Purified NK cells were primed overnight
with IL-15 and IL-18 (10 ng/ml each) and then challenged with CpG-ODN (1
M). Nuclear translocation of p65 was measured by immunofluorescence
after 60-min stimulation. Hoeschst was used to stain the nucleus. B, to quan-
tify the results shown inA, the percentage of nuclear translocationwas deter-
mined by counting 100 cells. The figure is representative of three indepen-
dent experiments. ***, p  0.001 versus unstimulated cells (control) using
one-way ANOVA and Fisher least significance difference test.
FIGURE 3. Purified spleen NK cells from WT and mice deficient for MyD88,
TLR9, STING, TRIF, UNC93b1, IFN-/R, and IL-12RB2 were stimulated with
accessory cytokines (IL-15 and IL-18 at 10 ng/ml each) and CpG-ODN (1 M)
for 48 h, and IFN- (A) and GM-CSF (B) weremeasured in the supernatants by
ELISA. The MyD88 inhibitory peptide (MyD-Pep) was also applied on the
sting/ cells at 25 M. Data are mean S.E. of five experiments. *, p 0.05;
*, p 0.01; ***, p 0.001 versus WT using one-way ANOVA and Fisher least
significance difference test. C, purified NK cells were primed overnight with
IL-15 and IL-18 (10 ng/ml each) and challengedwith CpG-ODN (1M) in pres-
ence of GolgiStop. IL-12p40/70was then stained intracellularly using specific
antibodies anddetected on the gatedNKp46 cells. The left histogram shows
the IL-12p40/70 stain as percentage of positive cells, themiddle graph shows
the mean fluorescence intensity (MFI), and the right histograms show the
expression of IL-12R2 on the NK cells cultured in the same conditions. Data
are the mean  S.E. of five experiments. ***, p  0.001 versus cells without
stimulation (control) using one-way ANOVA and Fisher least significance dif-
ference test. D, purified NK cells were stimulated with IL-15/IL-18 and CpG-
ODN labeled with A488. After 60 min, the cells were fixed, stained with an
anti-STING antibody, and processed for confocal microscopy. The nucleus is
visualized with Hoechst. Arrows indicate spots where an proximally overlap-
ping was observed for cytosolic STING and speckled CpG-ODN stain.
Cytokine Signaling of CpG-ODN in NK Cells
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induction. For this purpose, we utilized ifn-g/ NK cells to
study the influence on GM-CSF and anti-GM-CSF blocking
antibodies to measure the effect of GM-CSF on IFN- produc-
tion. Our results indicate that the lack of IFN- had no influ-
ence on GM-CSF, and the blockage of GM-CSF did not alter
IFN- production.
To determine whether the TLR9-independent and STING-
dependent cytokine production was specific of NK cells, we
measured cytokine production by macrophages in response to
CpG-ODN. Because GM-CSF production was extremely low
(below 30 pg/ml), we measured IL-1, IL-6, and TNF (Fig. 4).
We found that cytokine production by STINGdeficientmacro-
phages was not reduced as compared with WT macrophages,
whereas it was significantly diminished in the absence of
MyD88, TLR9, or with the blockade of MyD88 (MyD peptide)
as classically reported. In contrast to STING, the response to
CpG-ODN in macrophages was dependent on UNC93b1, sim-
ilar to NK cells.
Participation of IL-12 in IFN- andGM-CSF Induction inNK
Cells—Interestingly, the production of IFN- and GM-CSF by
NK cells was totally abolished in the absence of IL-12R2, one
of the two chains forming the IL-12 receptor (Fig. 3, A and B).
IL-12 is usually derived fromaccessory cells but considering the
high experimental purity (95%), the capacity of NK cells to
produce IL-12 and self-activate by an autocrine actionwas con-
sidered. We chose to analyze IL-12 production by flow cytom-
etry and intracellular staining for two reasons. First, IL-12 pro-
duction may be below the threshold of classical ELISA, and
second, the cytokinemay be consumed by NK cells themselves.
A tangential example is type I IFNs, which are easily measured
by RT-PCR but very hard to detect by ELISA in culture super-
natants. As shown in Fig. 3C, IL-12-positive NK cells were
barely detected when stimulated by CpG-ODN or IL-15/IL-18
alone, both in terms of percentage of positive cells and mean
fluorescence intensity. In contrast, IL-15/IL-18 and CpG-ODN
synergized and induced a significant increase in IL-12-positive
NK cells. Although in these culture conditions the percentage
of positive cells remained low, IL-12 was significantly increased
in comparison to unstimulated cells or cells stimulated with
CpG-ODN or IL-15/IL-18 alone. The different stimulations
(CpG-ODN and/or accessory cytokines) had no effect on the
expression of the IL-12R2 chain.
STING and CpG-ODN Overlap in NK Cell Cytoplasm—Fi-
nally, we investigated whether STING and CpG-ODN over-
lapped in NK cells. As shown in Fig. 3D, STING was strongly
expressed in the cytoplasm of NK cells. The figure shows NK
cells stimulatedwith IL-15/IL-18 andCpG-ODN, but the result
was similar without accessory cytokines. It can be seen, thanks
to A488-labeled CpG-ODN, that there is an uptake of the
oligodeoxynucleotide by the NK cells. Confocal microscopy
shows that STING and CpG-ODN overlap in different loca-
tions within the NK cells (white arrows in the merge).
DISCUSSION
In a previous report, we showed by flow cytometry that sim-
ilar to myeloid cells, TLR9 was intracellular in murine NK cells
(11). TLR9 is a pattern recognition receptor sensing unmethyl-
ated bacterial DNA whose triggering is mimicked by CpG-
ODN. CpG-ODN stimulation induced cytokine production by
macrophages and dendritic cellmaturation, a response thatwas
absent for cells from tlr9/ mice (23). Additionally, the TLR
adaptor protein MyD88 is involved, co-localized with TLR9,
and tagged CpG-ODN into the endosome compartment (24).
In the present report, we confirmed the intracellular localiza-
tion of TLR9 inNK cells and in addition showed that it overlaps
with the Golgi apparatus.
In a previous study, we also found that purified splenic naive
NK cells were highly responsive to CpG-ODN, in terms of
IFN- and GM-CSF production, but only in the presence of
accessory cytokines such as IL-2, IL-15, and/or IL-18 (11),
which alone are unable to induce cytokine production.
To better understand the synergy between accessory cyto-
kines (IL-15/IL-18) and CpG-ODN and their signaling in NK
cells, we analyzed the phosphorylation of signaling molecules
described in the literature to be induced by them. We found
that IL-15 and IL-18 alone and/or together induced the phos-
phorylation of c-Jun and IB, which is consistent with the
literature, where IL-15 has been shown to activate the JNK and
NF-Bpathways inmyeloid cells (25).Nevertheless, in the pres-
ence of CpG-ODN and IL-15/IL-18, their phosphorylation
appeared more sustained at 1 h as compared with IL-15/IL-18
alone. CpG-ODN and IL-18 also induced STAT3 phosphory-
lation, and the level was again higher when stimulatory cyto-
FIGURE 4.Purified peritonealmacrophages fromWTand knock-outmice
for MyD88, TLR9, STING, TRIF, UNC93b1, IFN-/R, and IL-12R2 were
stimulatedwith CpG-ODN (1M) for 24 h, and IL-1 (A), IL-6 (B), and TNF
(C) were measured in the supernatants by ELISA. The MyD88 inhibitory
peptide (MyD-Pep) was also applied on the sting/ cells at 25 M. Data are
the mean  S.E. of five experiments. *, p  0.05; *, p  0.01; ***, p  0.001
versusWTusing one-way ANOVA and Fisher least significance difference test.
Cytokine Signaling of CpG-ODN in NK Cells
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kines and CpG-ODN were added simultaneously. The contri-
bution of NF-B and STAT3 on IFN- and GM-CSF
production byNK cells was confirmed using specific inhibitors.
In addition, using microscopy and immunofluorescence, we
showed that no or low nuclear localization of NF-B was pres-
ent in cells stimulated with CpG-ODN or IL-15/IL-18 alone. In
contrast, the p65 subunit of NF-B revealed a high nuclear
localization after challenge with both CpG-ODN and IL-15/IL-
18. Finally, using specific inhibitors, we observed that IFN-
and GM-CSF secretion was independent of PI3K but partially
dependent on ERK1/2 for IFN- and p38 for GM-CSF.
Using deficient mice, we evaluated whether IFN- and GM-
CSF productions were fully dependent of the TLR9 signaling
pathway for NK cells. In the case of IFN-, we demonstrated an
absence of production in myd88 and tlr9/ NK cells, which
was consistent with the literature. Interestingly, IFN- produc-
tion was also absent in unc93b1/ NK cells. UNC93b1 has
been described to play an important role for TLR9 migration
from the endoplasmic reticulum, where TLR9 is retained (26),
to the Golgi apparatus, and then to the endosomal compart-
ment where it encounter its agonist hypomethylatedDNA after
cellular uptake (27, 28). In addition, we found a partial effect of
STING on IFN- production by NK cells. Indeed, IFN- levels
were significantly decreased for STING-deficient NK cells
identifying a new actor involved in CpG-ODN sensing. STING
is a newly described cytoplasmic adaptor involved in the sens-
ing double-stranded DNA (22), which localizes near the endo-
plasmic reticulum in the presence of intracellular DNA (29).
We found that STINGabsencewas necessary for optimal IFN-
production byNK cells. In contrast to IFN-, which wasmostly
dependent on the classical TLR9 and MyD88 pathway, GM-
CSF production was profoundly and significantly altered in the
absence of STING and UNC93b1. Thus, we identified STING
as a new actor in CpG-ODN sensing in NK cells, adding an
intracytoplasmic detection of DNA in addition to the classical
endosomal TLR9-dependent detection system. STING is
involved in cytosolic DNA sensing, but it is an ER adaptor pro-
tein (29). Regarding UNC93b1, it has been predicted to be a
multispanning transmembrane protein (30) and similarly to
STING has been located in the ER (31). Thus, one canmake the
assumption that UNC93b1 may be also important for STING
function and/or correct location, as already shown for TLR3,
TLR7, and TLR9.
The TLR9-independent and STING-dependent cytokine
production was specific of NK cells and was not found in
macrophages. This negative result in macrophages does not
exclude a role of STING in other cell types. For example,
Landrigan et al. (32) recently identified a TLR9-, MyD88-,
and endosomal-independent sensing of CpG-ODN in CD4
T lymphocytes but did not identify the receptor responsible for
CPG-ODN detection. It would be intriguing to verify whether
similarly to NK cells, STING is the molecule involved in this
sensing inT lymphocytes. In contrast to STING the response to
CpG-ODN in macrophages was dependent on UNC93b1, sim-
ilar to NK cells. The latter is most probably due to the fact that
UNC93b1 allows the endosomal localization of TLR9, as
reported previously (21). Finally, we found that STING and
CpG-ODN overlapped in NK cells. This result is consistent
with the observation by Hagele et al. (33) that DNA oligonu-
cleotides present in endosomes may reach the cytoplasm. The
existence of STING as an alternative cytosolic sensor for bac-
terial DNAmay be an advantage for the detection of intracyto-
plasmic bacteria.
As expected, the production of both cytokines was indepen-
dent of TRIF. This result is in accordance with the literature
where TRIF has been shown to be involved in TLR3 and TLR4
signaling pathways (34, 35) but not TLR9.We also investigated
a possible role of IFN-/, considering type I interferons have
been described to primeNK cells for cytotoxicity or IFN- pro-
duction (36, 37). Even if this effect appears to be related to
antiviral response and sensing of poly-I:C (dsRNA), we wanted
to ensure that type I interferons did not affect NK cell response
to CpG-ODN. Using inf-/R / NK cells, we showed that
indeed they do not participate in the induction mechanisms of
IFN- or GM-CSF.
Our results indicate that the lack of IFN- had no influence
on GM-CSF and the blockage of GM-CSF did not alter IFN-
production. In contrast and interestingly, the production of
IFN- and GM-CSF by NK cells was totally abolished in the
absence of IL-12R2, one of the two chains forming the IL-12
receptor. This suggests that IL-12 is necessary for the priming
of NK cells, whereas IL-2, IL-15, and IL-18 alone or in combi-
nation are unable to induce cytokine production bymurine NK
cells. IL-12 is the only cytokine able to activateNK cells without
the need of additional stimulus such as TLR agonists (3, 11).
IL-12 is usually derived fromaccessory cells but considering the
high experimental purity (95%), the capacity of NK cells to
produce IL-12 and self-activate by an autocrine actionwas con-
sidered. We show that IL-15/IL-18 and CpG-ODN synergized
and induced a significant increase in IL-12-positive NK cells.
The different stimulations (CpG-ODN and/or accessory cyto-
kines) had no effect on the expression of the IL-12R2 chain.
Taken together, the present data underlie the existence of an
alternativemechanismof sensing and response toCpG-ODN, a
typical TLR9 agonist. This signaling pathway in NK cells
involves STING, a recently described cytosolic adaptor
involved in the sensing of DNA. This pathway contributes fully
to GM-CSF production by NK cells and partially to that of
IFN. Furthermore, the production of both cytokines is
dependent on IL-12, produced by NK cells themselves. Detec-
tion of bacterial DNA contributes to the immune response for
several infections. The discovery of this alternative pathway
brings insight into the understanding of bacterial DNA sensing
and may be useful for the design of new vaccine adjuvant
therapies.
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